124 related articles for article (PubMed ID: 6194881)
41. A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma.
O'Neill PA; Butt M; Eswar CV; Gillis P; Marshall E
Melanoma Res; 2006 Jun; 16(3):245-8. PubMed ID: 16718271
[TBL] [Abstract][Full Text] [Related]
42. A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.
Middleton MR; Lorigan P; Owen J; Ashcroft L; Lee SM; Harper P; Thatcher N
Br J Cancer; 2000 Mar; 82(6):1158-62. PubMed ID: 10735499
[TBL] [Abstract][Full Text] [Related]
43. A phase II study evaluating the effect of tamoxifen on DNA repair in melanoma patients treated with dacarbazine.
Saunders MP; Salisbury AJ; O'Byrne KJ; Souliotis VL; Varcoe SM; Talbot DC; Kyrtopoulos SA; Harris AL
Anticancer Res; 1997; 17(6D):4677-80. PubMed ID: 9494588
[TBL] [Abstract][Full Text] [Related]
44. [Combination of dacarbazine, cisplatin and interferon alpha in the treatment of metastatic melanoma].
Tessier MH; Mansat E; Legoux B; Litoux P; Dreno B
Ann Dermatol Venereol; 1996; 123(9):538-42. PubMed ID: 9615103
[TBL] [Abstract][Full Text] [Related]
45. The chemohormonal therapy of metastatic melanoma: possible benefit of tamoxifen.
Crowell EB; Higa GM
W V Med J; 1993 Jun; 89(6):233-5. PubMed ID: 8322461
[TBL] [Abstract][Full Text] [Related]
46. Combination hepatic arterial infusion therapy is effective for ocular melanoma metastasis to the liver.
Ueda H; Hamagami H; Tanaka H; Kida Y; Ichinose M
Oncol Rep; 2005 Dec; 14(6):1543-6. PubMed ID: 16273253
[TBL] [Abstract][Full Text] [Related]
47. Chemotherapy for stage 4 melanoma: a three-year experience with cisplatin, DTIC, BCNU, and tamoxifen.
Reintgen D; Saba H
Semin Surg Oncol; 1993; 9(3):251-5. PubMed ID: 8516613
[TBL] [Abstract][Full Text] [Related]
48. [Chemotherapy in combination with laser coagulation or interstitial hyperthermia--effective combined therapy for disseminated skin melanoma].
Akimov MA; Gel'fond ML; Gershanovich ML; Barchuk AS
Vopr Onkol; 2003; 49(3):312-5. PubMed ID: 12926212
[TBL] [Abstract][Full Text] [Related]
49. [Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma].
Célérier P; Dreno B; Bureau B; Litoux P
Ann Dermatol Venereol; 1993; 120(6-7):437-40. PubMed ID: 8279787
[TBL] [Abstract][Full Text] [Related]
50. Treatment of patients with metastatic melanoma with a one day regimen of dacarbazine, vincristine, bleomycin and lomustine plus interferon-alpha.
Vuoristo M; Gröhn P; Kumpulainen E; Korpela M
Eur J Cancer; 1994; 30A(3):420. PubMed ID: 7515632
[No Abstract] [Full Text] [Related]
51. Single drug and combination chemotherapy in the treatment. Disseminated malignant melanoma.
Aranha GV; Grage TB
Minn Med; 1977 Aug; 60(8):543-8. PubMed ID: 882082
[No Abstract] [Full Text] [Related]
52. [Late results of the conservative treatment of melanoma of the skin].
Kogoniia LM; Manziuk LV; Marenich AF; Osmanov DSh; Roshchin EM
Sov Med; 1986; (11):101-2. PubMed ID: 3563661
[No Abstract] [Full Text] [Related]
53. [Primary malignant melanomas of the oral cavity. Apropos of a case].
Solanellas Soler J; Soldado Patiño L; Nieto Cortijo JM; Miralles Sanchiz J
Acta Otorrinolaringol Esp; 1988; 39(4):277-80. PubMed ID: 2483821
[No Abstract] [Full Text] [Related]
54. [Chemotherapy in disseminated malignant skin melanoma with a combination of nitrosomethylurea, vincristine, peplomycin or bleomycetin].
Tanaev VG; Gershanovich MA
Vopr Onkol; 1991; 37(2):162-7. PubMed ID: 1707570
[TBL] [Abstract][Full Text] [Related]
55. Analysis of the clinical utility of a predictive chemosensitivity assay.
Korn EL; Sondak VK; Bertelsen CA; Kern DH
Stat Med; 1985; 4(4):527-34. PubMed ID: 2418477
[TBL] [Abstract][Full Text] [Related]
56. The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy.
Hernberg M; Muhonen T; Turunen JP; Hahka-Kemppinen M; Pyrhönen S
J Clin Oncol; 1996 May; 14(5):1690-6. PubMed ID: 8622089
[TBL] [Abstract][Full Text] [Related]
57. Disseminated melanoma--is there a new standard therapy?
Guerry D; Schuchter LM
N Engl J Med; 1992 Aug; 327(8):560-1. PubMed ID: 1635572
[No Abstract] [Full Text] [Related]
58. Angiotensin-induced hypertension and chemotherapy for multiple lesions of malignant melanoma.
Takematsu H; Tomita Y; Kato T
Br J Dermatol; 1985 Oct; 113(4):463-5. PubMed ID: 2415150
[TBL] [Abstract][Full Text] [Related]
59. [Adjuvant chemotherapy of malignant melanoma of the female genital organs].
Inoue S; Shibata S; Tohya T; Munemura M; Fujisaki S; Maeyama M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):135-8. PubMed ID: 3456398
[No Abstract] [Full Text] [Related]
60. Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma.
Mulder NH; Sleijfer DT; de Vries EG; Schraffordt Koops H; Samson MJ; Willemse PH
J Cancer Res Clin Oncol; 1989; 115(1):93-5. PubMed ID: 2466036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
